Wanqing Liu

Wanqing Liu is Professor of Pharmaceutical Sciences and Pharmacology at Wayne State University School of Medicine. He directs research at the Liu Lab focusing on omics-based approaches for metabolic diseases and cancer.

Research spans four key areas: 1) Genomics of NAFLD/NASH using multi-omics integration; 2) Precision nutrition and genotype-based therapies; 3) Pharmacogenomics of drug metabolism across ages; 4) Germline-somatic mutation interactions in cancer. Current projects investigate miRNA-lipid networks in liver disease and siRNA-based therapeutics.

Recent publications demonstrate strong focus on lipid metabolism dysregulation in cancers (renal/liver), environmental toxicology (PFAS), and viral comorbidities. Article keywords show recurrent themes in molecular oncology, metabolic regulation, and genetic epidemiology.